AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $13.5K in total
- 4
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 18
- 13F valueReported value at the end of Q2 2026
- $325.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding AIM, Q2 2026
No superinvestor reported holding AIM at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by AIM ImmunoTech Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 (view filing)8:30 AM ET | Sep 17 | 1 day | Equels Thomas KCEO & President | PPurchase | +24.0K | $0.208 | +$4.99K | +23.3%126.8K after | |
| Sep 17, 2026 (view filing)12:01 PM ET | Sep 16 | 1 day | Equels Thomas KCEO & President | PPurchase | +11.0K | $0.21 | +$2.31K | +12.0%102.8K after | |
| Sep 16, 2026 (view filing)9:15 AM ET | Sep 15 | 1 day | Equels Thomas KCEO & President | PPurchase | +22.0K | $0.221 | +$4.86K | +31.5%91.8K after | |
| Sep 15, 2026 (view filing)4:30 PM ET | Sep 14 | 1 day | Equels Thomas KCEO & President | PPurchase | +5.90K | $0.219 | +$1.29K | +9.2%69.8K after | |
| Jun 16, 2025 (view filing) | Jun 13 | 3 days | Equels Thomas KCEO & President | PPurchase | +107 | $7.70 | +$823.9 | +0.3%38.9K after | |
| Jun 13, 2025 (view filing) | Jun 12 | 1 day | Equels Thomas KCEO & President | PPurchase | +103 | $8.70 | +$896.1 | +0.3%38.7K after | |
| Apr 23, 2025 (view filing)4:35 PM ET | Apr 11 | 12 daysLate | Mitchell William MDirector | PPurchase | +196.9K | $0.0254 | +$5.00K | +60.6%521.7K after | |
| Apr 23, 2025 (view filing)4:35 PM ET | Apr 11 | 12 daysLate | Equels Thomas KCEO & President | PPurchase | +1.97M | $0.0254 | +$50.0K | +103.7%3.87M after | |
| Apr 23, 2025 (view filing)4:35 PM ET | Apr 11 | 12 daysLate | Kellner Ted DDirector | PPurchase | +1.97M | $0.0254 | +$50.0K | +196,850.4%1.97M after | |
| Apr 7, 2025 (view filing)3:42 PM ET | Apr 4 | 3 days | Equels Thomas KCEO & President | PPurchase | +41.0K | $0.063 | +$2.58K | +2.2%1.90M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in AIM ImmunoTech Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 807,885 | $229.4K | 0.00% | +787,838+3,930.0% | Added |
| Virtu Financial LLC | 124,269 | $35.0K | 0.00% | +73,374+144.2% | Added |
| Morgan Stanley | 50,864 | $14.4K | 0.00% | +50,000+5,787.0% | Added |
| Geode Capital Management, LLC | 46,003 | $13.1K | 0.00% | +16,085+53.8% | Added |
| Goldman Sachs Group Inc | 32,444 | $9.21K | 0.00% | +32,444 | New |
| UBS Group AG | 28,931 | $8.22K | 0.00% | +28,930+2,893,000.0% | Added |
| Susquehanna International Group, LLP | 21,859 | $6.21K | 0.00% | +21,859 | New |
| Vanguard Fiduciary Trust Co | 17,519 | $4.97K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 12,222 | $3.47K | 0.00% | +12,222 | New |
| Tower Research Capital LLC (TRC) | 4,668 | $1.33K | 0.00% | 00.0% | Unchanged |